Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Brii Biosciences Broadens its Leadership in Hepatitis B with a Portfolio Now Addressing Disease's Burdens from Prevention to Cure 2023-07-06 07:25
Brii Biosciences Provides Latest Clinical Development and Corporate Updates 2023-07-06 07:19
New Survey Reveals Insights on Singapore Workers' Preparedness for Digital Transformation 2023-07-03 07:45
Wellcome and the Gates Foundation to Fund Late-Stage Development of a Tuberculosis Vaccine Candidate That Could Be the First in 100 Years If Proven Effective 2023-06-29 00:00
Brii Biosciences Announces Entry into Definitive Agreements from Sale of its Equity Interest in Qpex Biopharma and Acquiring Exclusive Global Rights for BRII-693 2023-06-26 07:30
Brii Bio Announces New Data from Partners Underscoring Potential for HBV Functional Cure at EASL™ Congress 2023 2023-06-25 20:00
The 'Penicillin' of Antivirals, Xafty by Hyundai Bioscience, Opened a New Era of Treating Respiratory Viral Infections with Single Drug 2023-06-18 03:30
Novavax Prepared to Deliver Protein-based Monovalent XBB COVID Vaccine Consistent with FDA VRBPAC Recommendation for the Fall 2023-06-16 06:05
Treating COVID with Metformin Reduces Long COVID Rates 2023-06-09 21:00
China Approves the World's First Vaccine against XBB Descendent Lineages of SARS-CoV-2 for Emergency Use 2023-06-09 11:59
CAMH study confirms ongoing brain inflammation associated with long COVID 2023-06-02 04:07
Brii Biosciences Announces First Subject Dosed in Phase 1 Clinical Trial of BRII-297, Long-Acting Injectable for the Treatment of Anxiety and Depressive Disorders 2023-06-01 08:00
Chula Researchers Discover "Highly Effective Antibodies against COVID-19," Leading to "COVITRAP Nasal Spray" to Curb Infection at the Start 2023-05-24 10:00
The First of Its Kind in the World: The Recombinant Multivalent COVID-19 Protein Vaccine against XBB Variants by WestVac Biopharma/West China Medical Center, Sichuan University has been Approved for Clinical Trials by The National Medical Products Administration of China. 2023-05-18 21:23
YS Biopharma to Participate in the Virtual Benchmark Healthcare House Call Conference on May 23, 2023 2023-05-18 20:25
Parliamentarians from 23 countries call on G7 leaders to invest in neglected tropical diseases 2023-05-17 17:40
YS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical Trial Approval in Pakistan 2023-05-16 19:00
Access to Novavax's COVID Vaccine Grows with Extended Interim Authorization for Adolescents in Singapore 2023-05-12 21:01
New report by the Global Hygiene Council (GHC) highlights critical role of hygiene in the fight against antimicrobial resistance and future pandemics 2023-05-05 20:14
Chula Researchers Develop Rapid MTB Strip Test for Tuberculosis 2023-05-03 11:34
1 2 3 4 5 70